The classification of LOC440900 Inhibitors pertains to a specific category of chemical compounds designed to modulate the activity of LOC440900, a molecular target currently under scientific investigation. These inhibitors are meticulously crafted through principles rooted in medicinal chemistry, with a focus on selectively interfering with the normal functions of LOC440900 within cellular processes. The structural composition of LOC440900 Inhibitors undergoes a rigorous optimization process, involving computational modeling and structure-activity relationship studies, to ensure the precision of their molecular configurations for effective binding to the target.
LOC440900 Inhibitors hold significance in the realm of molecular biology as they aim to disrupt the biochemical activities associated with LOC440900, which is presumed to play a pivotal role in various biological pathways. The ongoing research in this field seeks to unravel the three-dimensional structure of LOC440900 and its binding interactions with inhibitors, facilitating a deeper understanding of the molecular mechanisms underlying inhibition. The study of LOC440900 Inhibitors contributes to a broader comprehension of cellular processes and the intricate interplay of molecular components within biological systems. This research aids in expanding the scientific knowledge surrounding LOC440900, shedding light on its involvement in diverse biological functions and furthering our understanding of the complex regulatory networks governing cellular activities.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D binds to DNA and inhibits RNA polymerase, which could decrease the transcription of LINC01191. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
α-Amanitin inhibits RNA polymerase II, potentially reducing the transcription of LINC01191, which is likely transcribed by this polymerase. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
Known to inhibit the transcription of several genes by targeting RNA polymerase II, triptolide might decrease the expression of LINC01191. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $99.00 | 5 | |
Cordycepin is an adenosine analog that interrupts RNA synthesis, potentially reducing the stability and synthesis of LINC01191. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $42.00 $185.00 $310.00 $650.00 | 6 | |
DRB inhibits RNA polymerase II transcriptional elongation, which could suppress the expression of LINC01191. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
Flavopiridol inhibits CDK9, a component of the positive transcription elongation factor b (P-TEFb), which is required for RNA polymerase II transcription elongation, potentially leading to reduced expression of LINC01191. | ||||||
Leptomycin B | 87081-35-4 | sc-358688 sc-358688A sc-358688B | 50 µg 500 µg 2.5 mg | $105.00 $408.00 $1224.00 | 35 | |
By inhibiting exportin 1 (CRM1), leptomycin B could potentially increase nuclear retention of LINC01191, leading to its degradation within the nucleus. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $62.00 $178.00 | 8 | |
β-Estradiol can modulate gene expression through estrogen receptor signaling; this could potentially affect the transcription of genes, including LINC01191. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
JQ1 is a small molecule that inhibits BET bromodomain proteins, which can affect transcription regulation and potentially downregulate lncRNA expression, including LINC01191. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
RG108 is a DNA methyltransferase inhibitor, which could lead to changes in the methylation status of gene promoters, potentially affecting the expression of lncRNAs like LINC01191. | ||||||